Cipla Limited, a leading global pharmaceutical company headquartered in India, has been a pioneer in the healthcare industry since its establishment in 1935. With a strong presence in over 80 countries, Cipla focuses on developing a wide range of generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products.
Renowned for its commitment to affordable healthcare, Cipla has made significant strides in areas such as respiratory, cardiovascular, and anti-retroviral therapies. The company is distinguished by its innovative approach to drug development and its robust pipeline of products, which cater to diverse therapeutic needs.
Cipla's market position is bolstered by its extensive distribution network and strategic partnerships, making it a trusted name in the pharmaceutical sector. With numerous accolades for its contributions to global health, Cipla continues to lead the way in providing high-quality, accessible medicines.
+12 vs industry average
Cipla’s score of 50 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cipla?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Cipla's reported carbon emissions
In 2025, Cipla reported total carbon emissions of approximately 5.03 billion kg CO2e, comprising Scope 1 emissions of about 38.3 million kg CO2e, Scope 2 emissions of approximately 129.1 million kg CO2e, and Scope 3 emissions of around 4.86 billion kg CO2e. This represents a significant increase from 2024, where total emissions were approximately 4.58 billion kg CO2e. Cipla has set ambitious climate commitments, aiming for carbon neutrality in its India manufacturing operations by December 2025. This goal encompasses both Scope 1 and Scope 2 emissions, with plans to enhance energy efficiency and increase the use of renewable energy sources. Specifically, the company targets a reduction of Scope 1 emissions by 30% from 2020 levels by 2030 and aims to reduce Scope 2 emissions to near zero by 2025. Cipla's initiatives reflect a commitment to sustainability and align with industry standards for climate action, demonstrating a proactive approach to managing its carbon footprint. The company is on track to achieve its near-term goals, contributing to broader efforts in the pharmaceutical sector to mitigate climate change impacts.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cipla’s Climate Goals (2030 & 2050)
8 goals2030
25% reduction in Scope 2
We will reduce our Scope 2 emissions by 25% from 2020 levels by 2030.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 8 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
13 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project